Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.53978 | 22 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.44917 | 19 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.4546 | 19 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.3702 | 17 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.39054 | 18 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.50536 | 18 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.47533 | 18 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.42484 | 18 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.4091 | 18 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.43428 | 18 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.43217 | 18 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.41457 | 18 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.46938 | 20 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.43924 | 18 |